Oppenheimer Asset Management Inc. Sells 372 Shares of Docusign Inc (NASDAQ:DOCU)
Oppenheimer Asset Management Inc. decreased its holdings in shares of Docusign Inc (NASDAQ:DOCU) by 8.5% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 4,012 shares of the company’s stock after selling 372 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Docusign were worth $199,000 at the end of the most recent quarter.
Other institutional investors have also modified their holdings of the company. Oppenheimer & Co. Inc. increased its position in shares of Docusign by 116.0% in the 2nd quarter. Oppenheimer & Co. Inc. now owns 18,733 shares of the company’s stock valued at $931,000 after buying an additional 10,060 shares in the last quarter. Princeton Portfolio Strategies Group LLC bought a new stake in shares of Docusign in the 2nd quarter valued at $270,000. Russell Investments Group Ltd. increased its position in shares of Docusign by 27.9% in the 2nd quarter. Russell Investments Group Ltd. now owns 11,103 shares of the company’s stock valued at $554,000 after buying an additional 2,420 shares in the last quarter. Skandinaviska Enskilda Banken AB publ acquired a new position in Docusign in the 2nd quarter worth $328,000. Finally, Prudential Financial Inc. boosted its stake in Docusign by 47.4% in the 2nd quarter. Prudential Financial Inc. now owns 7,620 shares of the company’s stock worth $379,000 after purchasing an additional 2,450 shares during the period. Institutional investors own 69.76% of the company’s stock.
In other news, COO Scott V. Olrich sold 2,000 shares of the stock in a transaction dated Wednesday, September 11th. The shares were sold at an average price of $59.50, for a total transaction of $119,000.00. Also, insider Kirsten O. Wolberg sold 7,877 shares of the firm’s stock in a transaction dated Tuesday, June 25th. The shares were sold at an average price of $50.93, for a total transaction of $401,175.61. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 590,988 shares of company stock valued at $30,606,261. Company insiders own 13.60% of the company’s stock.
Shares of Docusign stock traded up $0.53 during trading hours on Friday, reaching $63.46. 64,505 shares of the company’s stock were exchanged, compared to its average volume of 3,732,308. The company has a 50 day moving average of $48.48 and a two-hundred day moving average of $52.36. Docusign Inc has a fifty-two week low of $35.06 and a fifty-two week high of $64.18. The company has a current ratio of 1.64, a quick ratio of 1.76 and a debt-to-equity ratio of 1.06. The stock has a market cap of $10.54 billion, a P/E ratio of -21.94 and a beta of 1.37.
Docusign (NASDAQ:DOCU) last posted its quarterly earnings data on Thursday, September 5th. The company reported $0.01 EPS for the quarter, topping the Zacks’ consensus estimate of ($0.23) by $0.24. Docusign had a negative net margin of 28.20% and a negative return on equity of 26.70%. The company had revenue of $235.61 million during the quarter, compared to the consensus estimate of $220.81 million. During the same period in the prior year, the business posted $0.03 EPS. The company’s quarterly revenue was up 41.0% on a year-over-year basis. As a group, analysts expect that Docusign Inc will post -1.04 earnings per share for the current fiscal year.
Docusign Company Profile
DocuSign, Inc provides cloud based software in the United States. The company offers e-signature solution that enables businesses to digitally prepare, execute, and act on agreements. The company sells its products through direct, partner-assisted, and Web-based sales. It serves enterprise businesses, commercial businesses, and small businesses, such as professionals, sole proprietorships and individuals.
Read More: What are no-load funds?
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Docusign Inc (NASDAQ:DOCU).
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.